Manulife's Strong Core Profits Overlooked as Market Bias Leaves Shares 10% Below Value

Manulife’s Strong Results Meet Market Skepticism

Last week, Manulife reported fourth-quarter core earnings per share of $1.12, surpassing analyst expectations by nearly 47%. For the entire year, core EPS climbed 8%, highlighting the company’s effective execution. Despite these impressive figures, the stock showed little enthusiasm, dipping slightly before the market opened and ending at $37.80. This muted response, despite a clear earnings beat, highlights a puzzling disconnect between fundamentals and market reaction.

Analysts remain optimistic. The consensus rating for the stock is a “Buy”, with an average 12-month price target of $51.50. This suggests the market is undervaluing Manulife by about 10% compared to its estimated fair value. Such a scenario is a classic case of behavioral finance at work: even when a company outperforms, investor sentiment can remain anchored to broader worries or past disappointments, preventing the stock from reflecting its true potential.

Psychological factors are clearly influencing the market’s response. The slight premarket dip, despite a significant earnings beat, points to deeper cognitive biases. Investors appear cautious about the sector and are allowing broader market uncertainties to overshadow positive company-specific news. This slow adjustment in valuation is often driven by loss aversion and recency bias—where investors focus on past setbacks or sector-wide issues rather than current improvements.

Behavioral Biases: Overlooking the Bullish Case

Taking a data-driven approach may help investors see beyond prevailing sentiment. For example, a backtest of a long-only RSI(14) oversold strategy on Manulife (MFC) from March 2024 to March 2026—buying when RSI(14) falls below 30 and selling when it rises above 70, after 20 days, or upon hitting a 10% gain or 5% loss—yielded the following:

• Strategy Return: 12.75%
• Annualized Return: 6.15%
• Maximum Drawdown: 1.23%
• Win Rate: 100%
• Total Trades: 1
• Average Hold Period: 16 days

This quantitative perspective offers additional insight into the stock’s price behavior, independent of market sentiment.

Several psychological biases are shaping the current market view:

• Loss Aversion: Investors are reacting strongly to a $1.5 billion drop in net income compared to last year, even though core earnings actually increased by 5%. The focus on net outflows of $9.5 billion from wealth management further anchors negative sentiment, overshadowing the 8% annual core EPS growth and strong Asian segment performance.
• Recency Bias: Recent negative events, such as a $232 million charge in the Alternative Long-Duration Assets portfolio and a 22% drop in US segment core earnings, are being given outsized importance. These recent setbacks are crowding out the longer-term positive trends.
• Confirmation Bias: The market is fixated on Manulife’s 17% forward P/E discount to banks, reinforcing a bearish outlook. However, analysts highlight strengths such as capital flexibility, reduced downside risk, and a path to over 18% core ROE by 2027—factors that are being ignored due to entrenched negative narratives.

Ultimately, these biases are distorting the market’s view. Despite a year of strong results and operational progress, the focus remains on losses, recent charges, and low valuation, causing the stock to trade below its intrinsic value. The bullish case is not lacking in substance—it’s simply being overlooked due to persistent psychological hurdles.

Strategic Progress vs. Market Sentiment

While market sentiment remains fixated on past losses and outflows, Manulife’s operational performance tells a different story—one of momentum and shareholder returns. The gap between these realities is striking.

• Growth in Asia: The Asian business continues to drive growth, with adjusted earnings up 24% year-over-year. This sustained trend contributed to record core earnings and new business results in 2025. Despite this, the market remains preoccupied with US segment challenges and global wealth outflows.
• Shareholder Returns: Manulife generated $6.4 billion in remittances from operating units in 2025, supporting a capital return policy of 65-75% of adjusted earnings. In practice, about C$5.4 billion was returned to shareholders through dividends and buybacks—roughly 72% of core earnings. This steady return is a compelling reason to invest, yet the market continues to focus on headline net income declines.
• Financial Strength: The company ended the year with a LICAT ratio of 136%, providing a strong capital buffer and reducing operational risk. Still, the stock trades at a 17% discount to banks on a forward P/E basis, failing to reflect this strength.

These are not abstract numbers—they represent a company executing its strategy, expanding in key markets, rewarding shareholders, and maintaining a solid balance sheet. Yet, market psychology—driven by loss aversion and recency bias—keeps the focus on recent setbacks, maintaining a gap between the company’s true progress and its market valuation.

What Could Shift Sentiment and Close the Valuation Gap?

The current discount on Manulife’s shares is a reflection of sentiment, not fundamentals. Several upcoming developments could help realign perception with reality:

• US Stop-Loss Reserving Cycle: The expected “release” phase in 2026 could lead to more stable and improved results for the US segment, as highlighted by TD Cowen’s Mario Mendonca. This would directly address concerns over recent earnings volatility.
• Key Metrics to Watch: Investors should monitor the $9.5 billion in net outflows from the Global Wealth & Asset Management unit for signs of stabilization or reversal, as well as improvements in the Alternative Long-Duration Asset portfolio following last quarter’s $232 million charge.
• Technical Momentum: Manulife’s Relative Strength (RS) Rating recently reached the 73rd percentile, indicating strong price performance. Sustained momentum, combined with fundamental improvements, could attract more investors and accelerate a sentiment shift.

In summary, the market’s current discount is a wager on continued challenges. However, a combination of cleaner US results, stabilizing wealth flows, a recovering asset portfolio, and ongoing technical strength could help close the gap between Manulife’s operational achievements and its market valuation.